ABCB1 p.Arg210Ala
| Predicted by SNAP2: | A: N (78%), C: N (78%), D: N (57%), E: N (72%), F: N (82%), G: N (78%), H: N (93%), I: N (72%), K: N (97%), L: N (78%), M: N (87%), N: N (93%), P: N (57%), Q: N (93%), S: N (93%), T: N (87%), V: N (78%), W: N (53%), Y: N (97%), |
| Predicted by PROVEAN: | A: D, C: D, D: D, E: N, F: D, G: D, H: N, I: D, K: N, L: D, M: D, N: N, P: D, Q: N, S: N, T: N, V: D, W: D, Y: N, |
[switch to compact view]
Comments [show]
None has been submitted yet.
[hide] Single nucleotide polymorphisms in multidrug resis... Adv Drug Deliv Rev. 2002 Nov 18;54(10):1311-31. Suzuki H, Sugiyama Y
Single nucleotide polymorphisms in multidrug resistance associated protein 2 (MRP2/ABCC2): its impact on drug disposition.
Adv Drug Deliv Rev. 2002 Nov 18;54(10):1311-31., [PMID:12406647]
Abstract [show]
Multidrug resistance associated protein 2 (MRP2/ABCC2), expressed on the bile canalicular membrane, plays an important role in the biliary excretion of various kinds of substrates. In addition, MRP2 is also expressed on the apical membrane of epithelial cells such as enterocytes. It is possible that the inter-individual difference in the function of MRP2 affects the drug disposition. In the present article, we will summarize the physiological and pharmacological role of MRP2, particularly focusing on the factors affecting its transport function such as single nucleotide polymorphisms and/or the induction/down regulation of this transporter. Mutations found in patients suffering from the Dubin-Johnson syndrome, along with the amino acid residues which are involved in supporting the transport activity of MRP2, are also summarized.
Comments [show]
None has been submitted yet.
No. Sentence Comment
120 It affecting MRP2 function was found that Lys24Ala (TM6), Lys483Ala (TM9), Arg210Ala (TM16) and Arg1257Ala (TM17) exhibit Several lines of investigation have been followed reduced transport activity for glutathione-conjugates to investigate the amino acid residues in MRP2 (Fig. 2) [111].
X
ABCB1 p.Arg210Ala 12406647:120:75
status: NEW